Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

84.75
Delayed Data
As of Jul 28
 -0.22 / -0.26%
Today’s Change
66.93
Today|||52-Week Range
86.90
+16.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Operating ActivitiesNet Income / Starting Line2.0B921.9M1.6B2.0B
 
 
 
 
 
Depreciation1.5B985.2M1.8B1.4B
 
 
 
 
 
Total Other Cash Flow-119.7M-782.6M12.9M67.6M
 
 
 
 
 
Funds From Operations3.4B1.1B3.4B3.5B
 
 
 
 
 
Funds From/For Other Operating Expenses116.0M-2.4B1.4B-161.4M
 
 
 
 
 
Net Cash Flow - Operating Activities3.3B3.5B2.0B3.6B
 
 
 
 
 
 
InvestingIncrease In Investments0.00-775.3M-14.9M14.9M
 
 
 
 
Decrease In Investments89.2M777.9M0.0023.1M
 
 
 
 
Capital Expenditures-449.6M-579.0M-340.8M-339.4M
 
 
 
 
 
Fixed Asset Disposal343.9M-799.6M349.8M262.1M
 
 
 
 
 
Net Assets From Acquisitions -107.1M-232.1M-653.0M-6.2M
 
 
 
 
 
Other Investing - Uses482.5M-371.8M-46.6M-41.0M
 
 
 
 
 
Other Investing - Sources-33.9M845.2M0.000.00
 
 
 
Net Cash Flow Investing-764.5M-1.1B-1.1B-356.1M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings109.1M-2.2B7.2B-1.1B
 
 
 
 
 
Long Term Debt Reduction----0.000.00--
Net Proceeds Stock Sale0.000.000.000.00--
Common Preferred Redeemed-412.8M-415.0M-1.0B-1.9B
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-42.7M29.3M-6.4B-100.4M
 
 
 
 
 
Other Sources - Financing-5.0M220.5M0.0013.1M
 
 
 
 
Other Uses - Financing9.0M-3.0M68.4M-68.4M
 
 
 
 
 
Net Cash Flow - Financing-360.4M-2.3B-384.4M-3.0B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash962.9K-381.2M8.9M51.5M
 
 
 
 
 
 
Net Change In Cash2.1B203.2M550.9M243.1M